调节器
脂质代谢
基因敲除
胆固醇
基因敲除
基因剔除小鼠
细胞生物学
化学
生物
生物化学
基因
作者
Tingting Li,Tao‐Hua Li,Juan Peng,Bei He,Lu-Shan Liu,Dangheng Wei,Zhi‐Sheng Jiang,Xi‐Long Zheng,Zhi-Han Tang
标识
DOI:10.1016/j.atherosclerosis.2017.11.033
摘要
Transmembrane 6 superfamily 2 (TM6SF2), a gene identified at the locus 19p12, has been recognized to regulate plasma lipids. Here, we provide an overview of the roles of TM6SF2 as a novel target for plasma lipid regulation. We first review the association of TM6SF2 variant with plasma lipid traits, cardiovascular disease (CVD) and non-alcoholic fatty liver disease (NAFLD). Then, we present an overview about the in vivo validation of TM6SF2 as a regulator of plasma lipid levels using mice, with overexpression or knockdown/knockout of TM6SF2. Thereafter, we discuss the mechanisms underlying TM6SF2 regulation of lipid metabolism involving intestinal cholesterol absorption and hepatic cholesterol biosynthesis and transport. In conclusion, increasing evidence suggests that TM6SF2 may be a major regulator of plasma lipid levels and become a therapeutic target in cardiovascular disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI